CDK Global Appoints Eileen Martinson and Steve Schuckenbrock to Its Board of Directors
Sep 06, 2016 20:05 pm UTC| Business
HOFFMAN ESTATES, Ill., Sept. 06, 2016 -- CDK Global, Inc. (Nasdaq:CDK) announced today that its board of directors has appointed two new highly qualified independent directors, Eileen J. Martinson and Stephen F....
Prothena Announces Appointment of Gene G. Kinney as Chief Operating Officer
Sep 06, 2016 20:05 pm UTC| Business
DUBLIN, Ireland, Sept. 06, 2016 -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development, and commercialization of novel protein immunotherapies, today...
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Sep 06, 2016 20:05 pm UTC| Business
TUSTIN, Calif., Sept. 06, 2016 -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend payment on the Company's 10.50% Series E...
Sep 06, 2016 20:05 pm UTC| Business
BELLEVUE, Wash., Sept. 06, 2016 -- Blucora, Inc. (NASDAQ:BCOR), today announced that John Clendening, president and chief executive officer, will present at the Goldman Sachs Sixth Annual Financial Technology Conference...
Paylocity to Present at the 2016 Deutsche Bank Technology Conference
Sep 06, 2016 20:05 pm UTC| Business
ARLINGTON HEIGHTS, Ill., Sept. 06, 2016 -- Paylocity Holding Corporation (Nasdaq:PCTY), a cloud-based provider of payroll and human capital management software solutions, today announced that its President and Chief...
Sep 06, 2016 20:05 pm UTC| Business
PITTSBURGH, Sept. 06, 2016 -- II‐VI Incorporated (NASDAQ:IIVI), a leading provider of pump laser modules and micro-optics for transceiver-embedded optical amplifiers, today announced the introduction of new uncooled 980...
Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences
Sep 06, 2016 20:05 pm UTC| Business
DEVON, Pa., Sept. 06, 2016 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that...